Burkitt lymphoma risk in U.S. solid organ transplant recipients

American Journal of Hematology

Volumn 88, Issue 4, 2013, Pages 245-250

  Mbulaiteye, Sam M ^a   Clarke, Christina A ^b,c   Morton, Lindsay M ^a   Gibson, Todd M ^a   Pawlish, Karen ^d   Weisenburger, Dennis D ^e   Lynch, Charles F ^f   Goodman, Marc T ^g   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CHILD; CLINICAL FEATURE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORGAN TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGED; REGISTRIES; RISK; SEX FACTORS; UNITED STATES;

EID: 84875592375     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23385     Document Type: Article

References (33)

1. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958;46:218-223.
2. Leoncini L, Raphael M, Stein H, et al., editors. Burkitt Lymphoma. Lyon: International Agency for Research on Cancer (IARC); 2008. pp 262-264.
3. Dalla-Favera R, Bregni M, Erikson J, et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982;79:7824-7827.
4. Klein G. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 1983;32:311-315.
5. Carpenter LM, Newton R, Casabonne D, et al. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: A case-control study in Uganda. Int J Cancer 2008;122:1319-1323.
6. Mutalima N, Molyneux E, Jaffe H, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: Results from a case-control study. PLoS ONE 2008;3:e2505.
7. Burkitt D. A children's cancer dependent on climatic factors. Nature 1962;194:232-234.
8. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-570.
9. Bornkamm GW. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue. Semin Cancer Biol 2009;19:351-365.
10. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194.
11. Picarsic J, Jaffe R, Mazariegos G, et al. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Cancer 2011;117:4540-4550.
12. Penn I. Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev 1988;12:39-57.
13. Zimmermann H, Reinke P, Neuhaus R, et al. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: Sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients. Cancer 2012;118:4715-4724.
14. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9 (Suppl 3):S1-S155.
15. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891-1901.
16. World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1976.
17. World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 1990.
18. World Health Organization. Classification of Diseases (ICD). In: Fritz A, Percy C, Jack A, et al., editors. International Classification of Diseases for Oncology (ICD-O-3). Geneva (Switzerland): World Health Organization; 2000.
19. Ogwang MD, Bhatia K, Biggar RJ, et al. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008;123:2658-2663.
20. Emmanuel B, Kawira E, Ogwang MD, et al. African Burkitt lymphoma: Age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011;84:397-401.
21. Mbulaiteye SM, Biggar RJ, Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009;53:366-370.
22. Guech-Ongey M, Simard EP, Anderson WF, et al. AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010;116:5600-5604.
23. Li J, Thompson TD, Miller JW, et al. Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 2008;121:e1470-e1477.
24. Levine PH, Kamaraju LS, Connelly RR, et al. The American Burkitt's Lymphoma Registry: eight years' experience. Cancer 1982;49:1016-1022.
25. Patte C, Auperin A, Michon J, et al. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370-3379.
26. Klein G. Burkitt lymphoma-A stalking horse for cancer research? Semin Cancer Biol 2009;19:347-350.
27. Mbulaiteye SM, Anderson WF, Bhatia K, et al. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer 2010;126:1732-1739.
28. Bellan C, Lazzi S, Hummel M, et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005;106:1031-1036.
29. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012;490:116-120.
30. Sander S, Calado DP, Srinivasan L, et al. Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis. Cancer cell 2012;22:167-179.
31. Giulino-Roth L, Wang K, Macdonald TY, et al. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. Blood 2012;120:5181-5184.
32. Quinlan SC, Morton LM, Pfeiffer RM, et al. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev 2010;19:1229-1237.
33. Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer 2006;119:2685-2691.